Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Gregory B Lesinski"'
Autor:
J. Harrison Howard, Naduparambil K. Jacob, Kala M. Levine, Zachary B. Abrams, William E. Carson, Tanios Bekaii-Saab, Lai Wei, Joseph Markowitz, Kelly Regan, John N Hassani, Gregory B. Lesinski, Xiaoli Zhang, Taylor R. Brooks, Kari Kendra, Thomas Olencki, Nicholas Latchana, Sarvani Uppati, Philip R. O. Payne
Publikováno v:
OncoTargets and therapy
Joseph Markowitz,1–4 Zachary Abrams,2,5 Naduparambil K Jacob,2,6 Xiaoli Zhang,2,7 John N Hassani,1 Nicholas Latchana,8 Lai Wei,2,7 Kelly E Regan,2,5 Taylor R Brooks,2 Sarvani R Uppati,2 Kala M Levine,2 Tanios Bekaii-Saab,2,4 Kari L Kendra,2,4 Grego
Autor:
Bhuvaneswari Ramaswamy, Charles L. Shapiro, Donn C. Young, Gregory B. Lesinski, John C. Byrd, Amy S. Ruppert, David M. Lucas, Kristy Culler, Diedre Wilkins, Larry J. Schaaf, Tanios Bekaii-Saab, Michael R. Grever, John J. Wright
Publikováno v:
Cancer Chemotherapy and Pharmacology. 66:151-158
A phase I study to determine the maximum tolerated dose (MTD) of bortezomib (B) when combined with weekly paclitaxel in patients with advanced solid tumors.Eligible patients received escalating doses of intravenous (IV) bortezomib (0.6-2 mg/m(2)) on
Autor:
Bethany L. Mundy-Bosse, Gregory B. Lesinski, Valerie P. Grignol, Bonnie Paul, Kari Kendra, Erinn M. Hade, Joseph Markowitz, Sri Vidya Kondalasula, Thomas Olencki, Taylor R. Brooks, William E. Carson, Thao-Vi Dao, Eric Luedke
The possibility that cytokine administration could enhance the antitumor effects of proteasome inhibition was explored. It was found that coadministration of bortezomib and interferon-α (IFN-α) induced synergistic apoptosis in human melanoma cell l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ce66528e6215766b2df1985557961c3
https://europepmc.org/articles/PMC4174542/
https://europepmc.org/articles/PMC4174542/
Publikováno v:
Journal of Surgical Research. 158:241-242
Autor:
Andrew Stiff, Flavia Pichiorri, Gregory B. Lesinski, Yvonne A. Efebera, Don M. Benson, Gerard J. Nuovo, Ashley E. Rosko, Douglas W. Sborov, Craig C. Hofmeister, Thomas A. Mace
Publikováno v:
Blood. 122:3208-3208
Introduction In relapsed/refractory multiple myeloma, approximately 50% of patients have Ras-family (NRAS and KRAS) activating gene mutations. Reovirus Serotype 3 - Dearing Strain (Reolysin) is the infusible form of the RNA human reovirus associated
Autor:
Gregory B. Lesinski, Ene T. Raig, Adrian Lewis, Page Bouchard, Llyod Brown, Michael R. Go, William E. Carson, Erinn M. Hade, Nisha N Shah
Publikováno v:
Journal of Immunotherapy. 28:622-623
Autor:
Erinn M. Hade, Thomas Olencki, Sri Vidya Kondalasula, Valerie P. Grignol, William E. Carson, Bethany L. Mundy-Bosse, Bonnie Paul, Thao-Vi Dao, Gregory B. Lesinski, Eric Luedke, Joseph Markowitz, Kari Kendra
Publikováno v:
Journal of Clinical Oncology. 31:e20018-e20018
e20018 Background: Preclinical studies revealed that bortezomib and interferon-α (IFN-α ) induce synergistic apoptosis in human melanoma cells. Combined treatment with bortezomib and IFN-α led to significant survival increases in a melanoma murine
Publikováno v:
Journal of Clinical Oncology. 26:20031-20031
20031 Background: Preclinical studies demonstrate synergistic activation of Caspase 3 and enhancement of survival with combination therapy. The primary objective: to determine the safety, tolerabil...
Autor:
William E. Carson, Gregory B. Lesinski, Erinn M. Hade, Nisha N Shah, Kristan D. Guenterberg, Page Bouchard, Michael R. Go, Adrian Lewis, Ene T. Raig
Publikováno v:
Journal of Surgical Research. 144:392